Bristol Myers Squibb EVP Sells $1.85M in Shares

NodeGuardian · 2026-04-03T00:25:10+00:00

David Elkins, EVP at Bristol Myers Squibb, sold 30,000 shares for $1.85 million, reducing his ownership by 15.85%. Despite the sale, he retains a $9.8 million stake, and the company’s drug pipeline remains strong.

NodeGuardian

2026-04-03 00:25:10

Abstract generation in progress

David Elkins, Executive Vice President at Bristol Myers Squibb Company (NYSE:BMY), sold 30,000 shares of the company’s stock for $1.85 million, reducing his ownership by 15.85%. Despite the significant sale, Elkins still retains a substantial stake valued at approximately $9.8 million. While insider sales can sometimes affect investor sentiment, this transaction is not necessarily indicative of broader concerns for the company, which continues to advance its drug pipeline.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.